5 Best Dividend Stocks According to Tiger Cub Rob Citrone

3. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 74
Dividend Yield as of February 2: 3.01%
Discovery Capital Management’s Stake Value: $25,638,000

Pfizer Inc. (NYSE:PFE), an American pharmaceutical and biotech company, announced a quarterly dividend of $0.40 per share on December 10, 2021. This represented a 2.6% increase in its dividend, as the company has been increasing its dividend consistently for the past 11 years. Moreover, Pfizer Inc. (NYSE:PFE) has been paying dividends to shareholders consecutively for 333 quarters, becoming one of the best dividend stocks in Rob Citrone’s portfolio.

Insider Monkey’s Q3 data showed that the number of hedge funds having stakes in Pfizer Inc. (NYSE:PFE) grew to 74, from 67 in the previous quarter. These stakes are valued at over $2.66 billion.

In Q3 2021, Discovery Capital Management increased its position in Pfizer Inc. (NYSE:PFE) by 80%, which constituted 1.91% of its 13F portfolio. The hedge fund held shares worth over $25.6 million in the company. On January 28, JPMorgan appreciated the company’s vaccine sales and further believes earnings to exceed expectations in 2022. The firm lifted its price target on Pfizer Inc. (NYSE:PFE) to $57, with a Neutral rating on the shares.

Saturna Capital mentioned Pfizer Inc. (NYSE:PFE) in its Q3 2021 investor letter. Here is what the firm has to say:

“The Fund’s strongest performer during the quarter was pharmaceutical manufacturer Pfizer. The company submitted trial data to the FDA for use of its COVID-19 vaccine for younger children, and it is widely expected that the FDA will approve it. Health authorities also began recommending booster shots of the Pfizer vaccine for select populations, further increasing demand for vaccinations.”